Articles about Pfizer

Pfizer to close Seagen manufacturing plant in Seattle area following $43B acquisition

Pharma giant Pfizer, fresh off its $43 billion acquisition of Seagen, said it will shut down construction on a new… Read More

How Pfizer’s $43B acquisition of Seagen may impact Seattle and broader biotech market

Editor’s note: William Canestaro is managing director at Seattle venture capital firm WRF Capital and leads the biotechnology investment team. … Read More

Pfizer wins regulatory approval for its $43B acquisition of Seattle-area biotech giant Seagen

Pfizer’s plan to acquire Seagen for $43 billion has cleared the necessary regulatory hurdles, the pharma titan announced Tuesday. The… Read More

Seagen filing details M&A negotiations with several companies before $43B Pfizer deal

Seagen fielded multiple offers before agreeing to a whopping $43 billion acquisition by pharma giant Pfizer. The Seattle-area company revealed… Read More

Tech Moves: David Shim to lead Foursquare-Factual merged company; former Gates Foundation CEO joins Pfizer board; and more

— Location data companies Foursquare and Factual are merging. The combined company will be led by Placed founder David Shim… Read More